RPT-Fitch: Pharma M&A Highlights Key Themes of Scale, R&D Risk, Tax
(Repeat for additional subscribers) May 14 (Reuters) - (The following statement was released by the rating agency) Three main themes have emerged from the recent spate of major pharmaceutical M&A, Fitch Ratings says. These are the quest for scale in consumer healthcare, the need to
